Anavex Life Sciences Corp (AVXL)

[bas2020]

Not sure why people are expecting to see detailed AD data when Missling said it'll be revealed in a peer-reviewed journal. These journals impose data embargos that limit what can be presented prior.

I'm fully expecting to see a journal that incorporates a wealth of information, covering several indications, raising the expectations of a generally effective drug for most all CNS disorders.

This has no impact on preparing NDAs; it's the same data.